Fem Dophilus
On sale on the US market (according to the DSLD)
Jarrow Formulas, food supplement from the US market
Fem Dophilus (Jarrow Formulas), a food supplement au code-barres 790011030058, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Jarrow Formulas
- Barcode
- 790011030058
- Form
- Capsule
- One serving
- 1 capsule
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Microcrystalline Cellulose, Hypromellose, Magnesium Stearate, Silicon Dioxide
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Proprietary Probiotic Blend | Blend | 155 mg |
| Lacticaseibacillus rhamnosus GR-1 | Micro-organism | not stated |
| Limosilactobacillus reuteri RC-14 | Micro-organism | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Fem Dophilus
Entered into DSLD on 23 February 2025. Withdrawn from the US market on 21 February 2024 (according to the DSLD).- Different quantity per serving : Proprietary Probiotic Blend: 134 mg in this version; 155 mg on the displayed label
Official label: Women's Fem Dophilus
Entered into DSLD on 18 July 2023. Withdrawn from the US market on 4 January 2024 (according to the DSLD).- Different quantity per serving : Proprietary Probiotic Blend: 134 mg in this version; 155 mg on the displayed label
Official label: Women's Fem Dophilus
Entered into DSLD on 16 June 2022. Withdrawn from the US market on 3 November 2022 (according to the DSLD).- Active ingredient added : Lactobacillus reuteri RC-14 (quantity not stated)
- Active ingredient added : Lactobacillus rhamnosus GR-1 (quantity not stated)
- Active ingredient removed : Lacticaseibacillus rhamnosus GR-1 (quantity not stated)
- Active ingredient removed : Limosilactobacillus reuteri RC-14 (quantity not stated)
- Different quantity per serving : Proprietary Probiotic Blend: 134 mg in this version; 155 mg on the displayed label
Official label: Women's Fem Dophilus
Entered into DSLD on 25 January 2020. Withdrawn from the US market on 15 October 2021 (according to the DSLD).- Active ingredient added : Lactobacillus reuteri RC-14 (quantity not stated)
- Active ingredient added : Lactobacillus rhamnosus GR-1 (quantity not stated)
- Active ingredient added : Total Probiotic Blend (quantity not stated)
- Active ingredient removed : Lacticaseibacillus rhamnosus GR-1 (quantity not stated)
- Active ingredient removed : Limosilactobacillus reuteri RC-14 (quantity not stated)
- Active ingredient removed : Proprietary Probiotic Blend (155 mg)
Official label: Women's Fem Dophilus
Entered into DSLD on 25 April 2019. Withdrawn from the US market on 7 October 2019 (according to the DSLD).- Active ingredient added : Lactobacillus reuteri, RC-14 (quantity not stated)
- Active ingredient added : Lactobacillus rhamnosus, GR-1 (quantity not stated)
- Active ingredient added : Total Probiotic Blend (quantity not stated)
- Active ingredient removed : Lacticaseibacillus rhamnosus GR-1 (quantity not stated)
- Active ingredient removed : Limosilactobacillus reuteri RC-14 (quantity not stated)
- Active ingredient removed : Proprietary Probiotic Blend (155 mg)
Official label: Women's Fem Dophilus
Entered into DSLD on 25 September 2015. Withdrawn from the US market on 13 February 2019 (according to the DSLD).- Active ingredient added : Lactobacillus reuteri RC-14 (quantity not stated)
- Active ingredient added : Lactobacillus rhamnosus GR-1 (quantity not stated)
- Active ingredient added : Total Probiotic Blend (5,000,000,000 Viable Cell(s))
- Active ingredient removed : Lacticaseibacillus rhamnosus GR-1 (quantity not stated)
- Active ingredient removed : Limosilactobacillus reuteri RC-14 (quantity not stated)
- Active ingredient removed : Proprietary Probiotic Blend (155 mg)
Official label: Women's Fem Dophilus
Entered into DSLD on 10 October 2014. Withdrawn from the US market on 1 May 2015 (according to the DSLD).- Active ingredient added : Lactobacillus reuteri, RC-14 (quantity not stated)
- Active ingredient added : Lactobacillus rhamnosus, GR-1 (quantity not stated)
- Active ingredient added : Total Probiotic Blend (5,000,000,000 Viable Cell(s))
- Active ingredient removed : Lacticaseibacillus rhamnosus GR-1 (quantity not stated)
- Active ingredient removed : Limosilactobacillus reuteri RC-14 (quantity not stated)
- Active ingredient removed : Proprietary Probiotic Blend (155 mg)
Official label: Fem Dophilus
Entered into DSLD on 24 December 2013. Withdrawn from the US market on 14 May 2013 (according to the DSLD).- Active ingredient added : Lactobacillus reuteri (quantity not stated)
- Active ingredient added : Lactobacillus rhamnosus (quantity not stated)
- Active ingredient added : Total Probiotic Blend (5,000,000,000 CFU)
- Active ingredient removed : Lacticaseibacillus rhamnosus GR-1 (quantity not stated)
- Active ingredient removed : Limosilactobacillus reuteri RC-14 (quantity not stated)
- Active ingredient removed : Proprietary Probiotic Blend (155 mg)
Official label: Fem Dophilus
Entered into DSLD on 24 December 2013. Withdrawn from the US market on 4 September 2014 (according to the DSLD).- Active ingredient added : Lactobacillus reuteri (quantity not stated)
- Active ingredient added : Lactobacillus rhamnosus (quantity not stated)
- Active ingredient added : Total Probiotic Blend (5,000,000,000 Viable Cell(s))
- Active ingredient removed : Lacticaseibacillus rhamnosus GR-1 (quantity not stated)
- Active ingredient removed : Limosilactobacillus reuteri RC-14 (quantity not stated)
- Active ingredient removed : Proprietary Probiotic Blend (155 mg)
Official label: Fem Dophilus
Entered into DSLD on 26 April 2012. Withdrawn from the US market on 14 May 2013 (according to the DSLD).- Active ingredient added : Lactobacillus reuteri, RC-14 (quantity not stated)
- Active ingredient added : Lactobacillus rhamnosus, GR-1 (quantity not stated)
- Active ingredient added : Total Probiotic Bacteria (quantity not stated)
- Active ingredient removed : Lacticaseibacillus rhamnosus GR-1 (quantity not stated)
- Active ingredient removed : Limosilactobacillus reuteri RC-14 (quantity not stated)
- Active ingredient removed : Proprietary Probiotic Blend (155 mg)
Older versions (1)
Official label: Fem Dophilus
Entered into DSLD on 26 April 2012. Withdrawn from the US market on 13 December 2013 (according to the DSLD).- Active ingredient added : Lactobacillus reuteri, RC-14 (quantity not stated)
- Active ingredient added : Lactobacillus rhamnosus, GR-1 (quantity not stated)
- Active ingredient added : Total Probiotic Bacteria (quantity not stated)
- Active ingredient removed : Lacticaseibacillus rhamnosus GR-1 (quantity not stated)
- Active ingredient removed : Limosilactobacillus reuteri RC-14 (quantity not stated)
- Active ingredient removed : Proprietary Probiotic Blend (155 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Jarrow Formulas
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Fem Dophilus (Jarrow Formulas): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/790011030058-fem-dophilus-jarrow-formulas, updated 22 February 2024.